Application

RADIUS

Radius Health, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90764757
Filing Date: 06/09/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90764757
MARK INFORMATION
*MARK RADIUS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT RADIUS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Radius Health, Inc.
*MAILING ADDRESS 22 Boston Wharf Road, 7th Floor
*CITY Boston
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02210
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 009 
*IDENTIFICATION Downloadable written articles in the field of osteoporosis and breast cancer research
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Pharmaceutical research and development; testing of pharmaceuticals
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing educational information on the use of pharmaceuticals
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Nicholas B. Hawkins
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Womble Bond Dickinson (US) LLP
STREET 100 Light Street, 26th Floor
CITY Baltimore
STATE Maryland
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 21202
PHONE 410-545-5827
EMAIL ADDRESS tmdocketing@wbd-us.com
OTHER APPOINTED ATTORNEY Peter B. Bromaghim, Carla H. Clements, Melissa G. Ferrario, Anne C. Fleeson, William S. Fultz, Jack B. Hicks, Timothy H. Hiebert, Sarah Anne Keefe, Laura A. Kees, Kelli A. Ovies, Randel S. Springer, Michael A. Tobin, Emily Scheible Whittaker, Jeffrey S. Whittle
CORRESPONDENCE INFORMATION
NAME Nicholas B. Hawkins
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmdocketing@wbd-us.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) sarah.keefe@wbd-us.com; nicholas.hawkins@wbd-us.com; elizabeth.sousa@wbd-us.com; alice.rogers@wbd-us.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 4
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1400
*TOTAL FEES PAID 1400
SIGNATURE INFORMATION
SIGNATURE /James harrington/
SIGNATORY'S NAME James Harrington
SIGNATORY'S POSITION Chief IP Counsel
SIGNATORY'S PHONE NUMBER 4844777804
DATE SIGNED 06/09/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90764757
Filing Date: 06/09/2021

To the Commissioner for Trademarks:

MARK: RADIUS (Standard Characters, see mark)
The literal element of the mark consists of RADIUS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Radius Health, Inc., a corporation of Delaware, having an address of
      22 Boston Wharf Road, 7th Floor
      Boston, Massachusetts 02210
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 009:  Downloadable written articles in the field of osteoporosis and breast cancer research
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Pharmaceutical research and development; testing of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing educational information on the use of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Nicholas B. Hawkins. Other appointed attorneys are Peter B. Bromaghim, Carla H. Clements, Melissa G. Ferrario, Anne C. Fleeson, William S. Fultz, Jack B. Hicks, Timothy H. Hiebert, Sarah Anne Keefe, Laura A. Kees, Kelli A. Ovies, Randel S. Springer, Michael A. Tobin, Emily Scheible Whittaker, Jeffrey S. Whittle. Nicholas B. Hawkins of Womble Bond Dickinson (US) LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      100 Light Street, 26th Floor
      Baltimore, Maryland 21202
      United States
      410-545-5827(phone)
      tmdocketing@wbd-us.com

Nicholas B. Hawkins submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Nicholas B. Hawkins
       PRIMARY EMAIL FOR CORRESPONDENCE: tmdocketing@wbd-us.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sarah.keefe@wbd-us.com; nicholas.hawkins@wbd-us.com; elizabeth.sousa@wbd-us.com; alice.rogers@wbd-us.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).

Declaration

Declaration Signature

Signature: /James harrington/   Date: 06/09/2021
Signatory's Name: James Harrington
Signatory's Position: Chief IP Counsel
Signatory's Phone Number: 4844777804
Signature method: Sent to third party for signature
Payment Sale Number: 90764757
Payment Accounting Date: 06/09/2021

Serial Number: 90764757
Internet Transmission Date: Wed Jun 09 17:58:31 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.X.XX-2021060917583104645
9-90764757-7804da051da10735ffd82beab9282
fbd9f2eb3eb8eac83906ca184c413cbae48-DA-5
8301078-20210609113245038314

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed